-
Neusch C, Böhme V, Riesland N, Althaus M, Moser A, 2000 The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen. J Neural Transm 107, 531-541
-
Neusch C, Runde D, Moser A, 2000 G-proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals. Neurochem Res 25, 1521-1526
-
Thümen A, Behnecke A, Qadri F, Bäuml E, Moser A, 2002 N-Methyl-Norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo. Neuroreport 13, 25-28
-
Bringmann G, Feineis D, God R, Peters K, Peters EM, Scholz J, Riederer F, Moser A, 2002 1-Trichloromethyl-1,2,3,4-tetrahydro-ß-carboline (TACLO) and related derivatives: Chemistry and biochemical effects on catecholamine biosynthesis. Bioorganic & Medicinal Chemistry 10, 2207-2214
-
Riederer F, Luborzewski A, God R, Bringmann G, Scholz J, Feineis D, Moser A, 2002 Modification of tyrosine hydroxylase activity by chloral derived b-carbolines in vitro. J Neurochem 81, 814-819
-
Thümen A, Albrecht P, Dodt Ch, Moser A, 2002 Neuroleptospirose: Eine vergessene Erkrankung. Aktuelle Neurologie 29, 409-413
-
Thümen A, Qadri F, Sarkar R, Moser A, 2002 GBR-12909 effect on dopamine outflow depends on phosphorylation in the caudate nucleus of the rat. Synapse 46, 72-78
-
Thümen A, Behnecke A, Qadri F, Moser A, 2003 N-Methyl-Norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioral changes. Int J Neuropsychopharmacology 6, 35-40
-
Maass A, Scholz J, Moser A, 2003 Modelled ligand-protein complexes elucidate the origin of substrate specificity and provide insight into catalytic mechanisms of phenylalanine hydroxylase and tyrosine hydroxylase. Eur J Biochem 270, 1065-1075
-
Moser A, Gieselberg A, Ro B, Keller Ch, Qadri F, 2003 Deep brain stimulation: response to neuronal high frequency stimulation is mediated through GABAA receptor activation in rats. Neuroscience Letters 341, 57-60
-
Moser A, Hagenah J, Kömpf D, 2003 Halluzinationen beim M. Parkinson. Der Nervenarzt 74, 376-386
-
Moser A, Thümen A, Qadri F, 2003 Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration. J Neurol Sci 216, 107-110
-
Scholz J, Klingemann I, Moser A, 2004 Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson’s disease. J Neurol Neurosurg Psychiat 75, 634-636
-
Li TL, Qadri F, Moser A, 2004 Neuronal electrical high frequency stimulation modulates presynaptic GABAergic physiology. Neuroscience Letters 371, 117-121
|